Gary B. Gordon Insider Profile
11 Followers
Gary B. Gordon, CMO at Ayala Pharmaceuticals, holds 72.51K shares in TriSalus Life Sciences (Ticker: TLSI), holds 0.00 shares in Ayala Pharmaceuticals (Ticker: AYLA). Most recently, Gary B. Gordon Bought ― shares of TriSalus Life Sciences on May 18, 2026 for an estimated value of $24.60K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-9.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Gary B. Gordon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gary B. Gordon
Gary B. Gordon's Trading History
Ayala Pharmaceuticals
Jan 23, 2023
―
Uninformative Sell
―
$0.00
TriSalus Life Sciences
May 18, 2026
Director
Informative Buy
24.60K
$247.26K
List of latest transactions for each holding click on a transaction to see Gary B. Gordon's performance on stock
You May Also Like
Gary B. Gordon insider profile FAQ
What is the percentage of profitable transactions made by Gary B. Gordon?
The percentage of profitable transactions made by Gary B. Gordon is 50%.
What is the average return per transaction made by Gary B. Gordon?
The average return per transaction made by Gary B. Gordon is -9.50%.
What stocks does Gary B. Gordon hold?
Gary B. Gordon holds: AYLA, TLSI stocks.
What was Gary B. Gordon’s latest transaction?
Gary B. Gordon latest transaction was an Informative Buy of $24.60K.
What was Gary B. Gordon's most profitable transaction?
Gary B. Gordon’s most profitable transaction was an Informative Buy of TLSI stock on May 18, 2026. The return on the trade was 12.50%.
What is Gary B. Gordon's role in Ayala Pharmaceuticals?
Gary B. Gordon's role in Ayala Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.